Affiliation: Maastricht University
Country: The Netherlands
- Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recoveryH Boon
Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht NUTRIM, Maastricht University, Maastricht, The Netherlands
Diabetologia 50:103-12. 2007..However, data on substrate source utilisation in type 2 diabetes are inconclusive...
- Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patientsH Boon
Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
Diabetologia 51:1893-900. 2008..In this study, we aimed to assess the impact of the AMPK activator 5-aminoimidazole-4-carboxamide riboside (AICAR) on both glucose and fatty acid metabolism in vivo in type 2 diabetic patients...
- Skeletal muscle fatty acid transporter protein expression in type 2 diabetes patients compared with overweight, sedentary men and age-matched, endurance-trained cyclistsM M A L Pelsers
Department of Movement Sciences, Maastricht University, Maastricht, The Netherlands
Acta Physiol (Oxf) 190:209-19. 2007..As such, skeletal muscle fatty acid transporter protein expression could play an important role in the etiology of insulin resistance and/or type 2 diabetes...